Showing results (111-120 of 141) with videos related to
Sort By:
Pageof 15
Global Change Biology|February 10, 2023
Assessing long-term impacts of cover crops on soil organic carbon in the central US Midwestern agroecosystemsZiqi Qin, Kaiyu Guan, Wang Zhou, et al.Annals of Surgical Oncology|July 24, 2015
Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of LymphedemaSheldon Feldman, Hannah Bansil, Jeffrey Ascherman, et al.Plos One|September 8, 2011
Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San FranciscoAlbert Y Liu, Eric Vittinghoff, Deborah E Sellmeyer, et al.BMC Infectious Diseases|January 6, 2025
Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San FranciscoKelvin Moore, Noelle Le Tourneau, Jasmin Alvarez, et al.Survey of Ophthalmology|March 13, 2016
Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysisAe Ra Kee, Julio J Gonzalez-Lopez, Aws Al-Hity, et al.American Journal of Medical Genetics. Part A|April 17, 2023
Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM-associated syndromesMichell M Lozano Chinga, Alison A Bertuch, Zeinab Afify, et al.Journal of Clinical Immunology|January 19, 2006
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruptionEmmanouil Papasavvas, Jay R Kostman, Brian Thiel, et al.Nature Communications|January 8, 2024
Knowledge-guided machine learning can improve carbon cycle quantification in agroecosystemsLicheng Liu, Wang Zhou, Kaiyu Guan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2026
Rapid Antiretroviral Therapy Restart and HIV Care Re-Linkage Support at a Sexual Health Clinic in San FranciscoNoelle Le Tourneau, Janessa Broussard, Catherine Pearson, et al.Pharmaceutics|September 23, 2022
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled AnalysisMaria Garcia-Cremades, Craig W Hendrix, Priya Jayachandran, et al.Pageof 15